Literature DB >> 16202055

Perceived safety of donor blood and blood substitutes for transfusion: the role of informational frame, patient groups and stress appraisals.

E Ferguson1, J Leaviss, E Townsend, P Fleming, K C Lowe.   

Abstract

Patients express concerns about the safety of donated blood. Do they have similar concerns about potential 'blood substitutes' and does the way information is presented on these options alter patients' perceptions? A two (informational frame: gain or loss) by four (transfusion type: human donor blood, human haemoglobin, bovine haemoglobin or perfluorocarbon emulsion substitutes) by three (patient group: adult haemophiliac/leukaemia patients, relatives/friends of haemophiliac/leukaemia patients and controls) between-subjects design was used. There were 82 patients, 118 relatives/friends and 263 controls from the UK. Blood substitutes were perceived as being significantly less safe than donor blood. Perceptions of safety were greater when transfusion information (regardless of transfusion type or patient group) was presented as gains rather than losses. Different demographic and psychological factors predicted perceived safety (e.g. sex) and perceived risk (e.g. age and experience).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202055     DOI: 10.1111/j.1365-3148.2005.00612.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  2 in total

1.  The perception of health care risk: patients, health care staff and society.

Authors:  Umberto Fiandra; Ida Marina Raciti; Roberto Mosso; Giuseppe Calipari; Marco Rapellino
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

2.  In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.

Authors:  Yan Sheng; Yuan Yuan; Changsheng Liu; Xinyi Tao; Xiaoqian Shan; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-04-14       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.